Omeprazole (Omeprazole) Patent Expiration, LOE Window & CMS Spending

Omeprazole (Omeprazole) by Dexcel Technologies: FDA Orange Book LOE 2030-01-31, 15 AB generics, $463.1M 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorDexcel Technologies
FDA Application & PathwayN022032 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2030-01-31
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors15
2024 CMS Total Public Spend$463.1M
2024 Medicare Part D Spend$366.7M
2024 Medicaid Spend$96.4M
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 773.6% 2-yr change)